Home › Blood Cancers › NCT05108519

Complications and Clinical Response in Cancer Patients Treated With Anti-VEGF-Related Therapies

A Prospective Study Evaluating Complications and Clinical Response in Cancer Patients Treated With Anti-VEGF-Related Therapies

Who can join

All ages · All sexes

Inclusion Criteria:

* Patients must be able to understand and be willing to sign a written informed consent document
* Patients must be receiving any anti-VEGF-related regimen in monotherapy or combination therapy

About the study

This study collects information about complications and clinical response in cancer patients treated with anti-VEGF-related therapies. This study aims to observe side effects that may happen to patients with advanced cancer who are treated with anti-VEGF related therapy. This may help doctors learn if there are any relationships between these side effects and how the disease may respond to treatment.

What is being tested

• Electronic Health Record Review (other)

Sponsor: M.D. Anderson Cancer Center · Participants: 170 · Started: Apr 8, 2019

Contact the study team

Official record on ClinicalTrials.gov — NCT05108519

Locations in the U.S.

Conditions

• Blood Cancers

From ClinicalTrials.gov, data retrieved Oct 2, 2026. Each study sets its own eligibility; the study team decides who can join.